Marshall W S, Whitesitt C A, Goodson T, Roman C, Rinkema L, Fleisch J H
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285.
Agents Actions. 1987 Aug;21(3-4):275-7. doi: 10.1007/BF01966489.
LY171883 is an orally active antagonist of leukotriene (LT) D4 and LTE4. A series of related compounds varying the position and nature of the alkyl side chain were synthesized and evaluated for their ability to block LTD4-induced contraction of guinea pig ileum. Maximal activity was obtained with n-propyl, n-butyl, and n-pentyl substituents with slightly reduced activity for longer side chains. Polar groups on the side chain substantially reduced activity. Thus, it appears that the leukotriene receptor site requires a nonpolar alkyl group of moderate size at the 3-position on this type of receptor antagonist.